Casualties of the weak IPO market

Investment Dealers' Digest notes that the initial public offering market has sputtered this year; volume has dipped 7 percent from last year. The biggest issuer casualty may be biotech and healthcare companies. Only nine healthcare IPOs have come to market this year. Last year, 48 issuers went public, so the industry is well off its pace. Several companies in recent weeks have cancelled at the eleventh hour, opting instead to sell out to existing public companies.

> The Investment Dealers' Digest article. (exclusively for FierceFinance readers)